反应详情

Acetic acid (0.023 mL), 2-(tert-butyldimethylsilyloxy)acetaldehyde (0.046 mL), and sodium triacetoxyborohydride (0.11 g) were sequentially added to a tetrahydrofuran (1.0 mL) solution of methyl 2-(2-(benzyloxy)-5-(piperidin-4-yl)benzamido)-4-phenylbenzoate (0.11 g), followed by stirring at room temperature for 13 hours. The solvent was evaporated under reduced pressure, and ethyl acetate was added to the residue. After removal of the insoluble substance by filtration, a saturated aqueous solution of sodium bicarbonate was added thereto. The organic layer was separated, washed with a saturated aqueous solution of sodium chloride, dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure. The obtained residue was purified by silica gel column chromatography [eluent: 100-92% chloroform/methanol] to obtain 0.13 g of methyl 2-(2-(benzyloxy)-5-(1-(2-(tert-butyldimethylsilyloxy)ethyl)piperidin-4-yl)benzamido)-4-phenylbenzoate as a white solid.

1. customThe solvent was evaporated under reduced pressure, and ethyl acetate
2. additionwas added to the residue
3. customAfter removal of the insoluble substance
4. filtrationby filtration
5. additiona saturated aqueous solution of sodium bicarbonate was added
6. customThe organic layer was separated
7. washwashed with a saturated aqueous solution of sodium chloride
8. dry with materialdried over anhydrous magnesium sulfate
9. customthe solvent was evaporated under reduced pressure
10. customThe obtained residue was purified by silica gel column chromatography [eluent: 100-92% chloroform/methanol]